Pharmacoequity and the Promise of GLP-1 Therapies in Cardiovascular Disease

By afschroeder • June 16, 2026

Essien UR, Joynt Maddox KE, Dusetzina SB. Pharmacoequity and the Promise of GLP-1 Therapies in Cardiovascular Disease. Circulation. 2026 Jun 16;153(24):1884-1886. doi: 10.1161/CIRCULATIONAHA.126.080521. Epub 2026 Jun 15. PMID: 42296211.

Tags: Costs and Cost Analysis, General Internal Medicine, glucagon-like peptide 1, Obesity, Pharmacoequity, Publications, Veterans Administration

Pager

Choo S. Pager. JAMA. 2026 Jun 17. doi: 10.1001/jama.2026.6134. Epub ahead of print. PMID: 42307957.

A is for ___ : Narrative Medicine Framework for Mental Health Empowerment and Self-Authorship in Asian American Communities

Yan MJ, Lee HJ, Yan AJ, Yan VC, Bahk JE, Chen JA, Trinh NT, Ng WYK, Lu FG. A is for _ : Narrative Medicine[...]

Update on Diet and Nutritional Therapies in Patients with Inflammatory Bowel Disease

Baniqued MR, Shah ND, Dominguez J, Parian AM. Update on Diet and Nutritional Therapies in Patients with Inflammatory Bowel Disease. Dig Dis Sci. 2026 Jun[...]